Status:
COMPLETED
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Eastern Research Group, Inc.
Conditions:
Diabetes Mellitus
Metabolic Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Since 2009, a programmatic community-based strategy (COPE) has been implemented to address health disparities among Navajo individuals living with multiple chronic conditions. COPE (Community Outreach...
Detailed Description
Study population: The study will take place on the Navajo Reservation and within Navajo Area IHS clinical facilities. The Navajo Reservation covers over 27,000 square miles in rural New Mexico and Ari...
Eligibility Criteria
Inclusion
- Diagnosis of diabetes
- Treated at a participating IHS facility corresponding to their home residence
Exclusion
- Not seen in one of the six participating clinical sites
Key Trial Info
Start Date :
November 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2015
Estimated Enrollment :
28813 Patients enrolled
Trial Details
Trial ID
NCT03326206
Start Date
November 1 2013
End Date
December 31 2015
Last Update
December 16 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinle Comprehensive Health Care Facility
Chinle, Arizona, United States, 86503
2
Tsehootsooi Medical Center
Fort Defiance, Arizona, United States, 86504
3
Kayenta Health Center
Kayenta, Arizona, United States, 86033
4
Crownpoint Health Center Facility
Crownpoint, New Mexico, United States, 87313